- Home
- FNKO vs SLGL Comparison
FNKO vs SLGL Comparison
Compare FNKO & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FNKO | SLGL |
|---|---|---|
| Founded | 2017 | 1997 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 192.7M | 159.7M |
| IPO Year | 2017 | 2018 |
Fundamental Metrics
Financial Performance| Metric | FNKO | SLGL |
|---|---|---|
| Price | $4.06 | $64.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $5.50 | ★ $110.00 |
| AVG Volume (30 Days) | ★ 1.1M | 26.0K |
| Earning Date | 03-05-2026 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $928,842,000.00 | $18,970,000.00 |
| Revenue This Year | N/A | $122.71 |
| Revenue Next Year | $10.54 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 62.04 |
| 52 Week Low | $2.22 | $4.02 |
| 52 Week High | $14.28 | $75.00 |
Technical Indicators
Market Signals| Indicator | FNKO | SLGL |
|---|---|---|
| Relative Strength Index (RSI) | 56.64 | 61.30 |
| Support Level | $3.89 | $59.00 |
| Resistance Level | $4.31 | $67.85 |
| Average True Range (ATR) | 0.30 | 7.96 |
| MACD | -0.01 | -0.32 |
| Stochastic Oscillator | 58.08 | 62.75 |
Price Performance
Historical ComparisonAbout FNKO Funko Inc.
Funko Inc is an USA based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.
About SLGL Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.